EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Implications of Senescent T Cells for Cancer Immunotherapy

Tetsuhiro Kasamatsu iD

Cancers · 14.12.2023 · 15 (24) · 5835

DOI: 10.3390/cancers15245835 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 14.12.2023. Verfasst von Tetsuhiro Kasamatsu. Beteiligte Einrichtung: Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 3-39-22 Showa-machi, Maebashi 371-8514, Gunma, Japan. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

T-cell senescence is thought to result from the age-related loss of the ability to mount effective responses to pathogens and tumor cells. In addition to aging, T-cell senescence is caused by repeated antigenic stimulation and chronic inflammation. Moreover, we demonstrated that T-cell senescence was induced by treatment with DNA-damaging chemotherapeutic agents. The characteristics of therapy-induced senescent T (TIS-T) cells and general senescent T cells are largely similar. Senescent T cells demonstrate an increase in the senescence-associated beta-galactosidase-positive population, cell cycle arrest, secretion of senescence-associated secretory phenotypic factors, and metabolic reprogramming. Furthermore, senescent T cells downregulate the expression of the co-stimulatory molecules CD27 and CD28 and upregulate natural killer cell-related molecules. Moreover, TIS-T cells showed increased PD-1 expression. However, the loss of proliferative capacity and decreased expression of co-stimulatory molecules associated with T-cell senescence cause a decrease in T-cell immunocompetence. In this review, we discuss the characteristics of senescent T-cells, including therapy-induced senescent T cells.

Schlagwörter

Stichwörter der Autor:innen

PD-1T-cell senescencetherapy-induced cellular senescence

Autor:innen und Institutionen

  • Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, 3-39-22 Showa-machi, Maebashi 371-8514, Gunma, Japan.

ORCID-Profile: Tetsuhiro Kasamatsu

Zitieren

APA

Kasamatsu, T. (2023). Implications of Senescent T Cells for Cancer Immunotherapy. Cancers, 15(24), 5835. https://doi.org/10.3390/cancers15245835

Vancouver

Kasamatsu T. Implications of Senescent T Cells for Cancer Immunotherapy. Cancers. 2023;15(24):5835. doi:10.3390/cancers15245835

BibTeX
@article{Kasamatsu2023,
  author = {Kasamatsu, Tetsuhiro},
  title = {Implications of Senescent T Cells for Cancer Immunotherapy},
  journal = {Cancers},
  year = {2023},
  volume = {15},
  number = {24},
  pages = {5835},
  doi = {10.3390/cancers15245835}
}
Kostenlos starten →